You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Colorcon
Baxter
Johnson and Johnson
Moodys

Last Updated: April 3, 2020

DrugPatentWatch Database Preview

Drug Price Trends for HYOSCYAMINE SULF


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for HYOSCYAMINE SULF

Average Pharmacy Cost for HYOSCYAMINE SULF

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
HYOSCYAMINE SULF 0.125 MG TAB 42192-0340-01 0.18849 EACH 2020-03-18
HYOSCYAMINE SULF 0.125 MG TAB 51525-0112-01 0.18849 EACH 2020-03-18
HYOSCYAMINE SULF 0.125 MG TAB 76439-0308-10 0.18849 EACH 2020-03-18
HYOSCYAMINE SULF 0.125 MG TAB 43199-0013-01 0.18849 EACH 2020-03-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Colorcon
McKesson
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.